Metabolomics was potent for the assessment of drug interaction.
Interaction between DHI and low-dose ASA would attach new influence on internal environment.
Eleven biomarkers were identified and seven metabolic pathways were constructed.
The biomarkers and metabolic pathways were associated with a lot of reported drugs and diseases.